Literature DB >> 23728233

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?

Anthony T Ruys1, Olivier R Busch, Dirk J Gouma, Thomas M van Gulik.   

Abstract

Entities:  

Year:  2012        PMID： 23728233      PMCID： PMC3392482          DOI： 10.1007/s13193-012-0153-3

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


× No keyword cloud information.
  5 in total

1.  American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions.

Authors:  Bas Groot Koerkamp; Jimme K Wiggers; Peter J Allen; Olivier R C Busch; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; Mithat Gonen; Dirk J Gouma; T Peter Kingham; Thomas M van Gulik; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-09-29       Impact factor: 3.647

Review 2.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

3.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

4.  Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients.

Authors:  Li Jingdong; Xiong Yongfu; Gang Yang; Xu Jian; Huang Xujian; Liu Jianhua; Zhao Wenxing; Qin Renyi; Yin Xinming; Zheng Shuguo; Liang Xiao; Peng Bin; Zhang Qifan; Li Dewei; Tang Zhao-Hui
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

5.  Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center.

Authors:  Jingdong Li; Yongfu Xiong; Gang Yang; Lixing Zhang; Muhammad Riaz; Jian Xu; Qiang Li; Zhaohui Tang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-07-16       Impact factor: 1.195
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.